{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:31:06Z","timestamp":1774625466288,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.psyneuen.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T13:19:42Z","timestamp":1449926382000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment"],"prefix":"10.1016","volume":"65","author":[{"given":"Chun-Yen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Chang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Shen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Hung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2015.12.003_bib0005","series-title":"Text Revision","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.schres.2007.06.014","article-title":"COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia","volume":"95","author":"Bertolino","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2014.02.015","article-title":"Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment","volume":"217","author":"Bosia","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1176\/appi.ajp.160.8.1413","article-title":"Is regionally selective D2\/D3 dopamine occupancy sufficient for a typical antipsychotic effect? an in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients","volume":"160","author":"Bressan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1601-183X.2010.00670.x","article-title":"Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese","volume":"10","author":"Chen","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2015.05.014","article-title":"Postprandial prolactin suppression appears absent in antipsychotic-treated male patients","volume":"60","author":"Coello","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0045","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0050","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia","volume":"35","author":"Endicott","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/jamapsychiatry.2014.2127","article-title":"Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies","volume":"72","author":"Furukawa","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0060","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.clinbiochem.2012.04.016","article-title":"Impact of catechol-O-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance","volume":"45","author":"Gao","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/14622416.10.3.385","article-title":"Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment","volume":"10","author":"Gupta","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4088\/JCP.12m08250","article-title":"The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study","volume":"74","author":"Heun","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia","volume":"66","author":"Howes","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.ALC.0000117832.62901.61","article-title":"Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence","volume":"28","author":"Huang","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/jpn.0718","article-title":"Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence","volume":"32","author":"Huang","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2009.10.004","article-title":"Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese","volume":"116","author":"Huang","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-0031-1291175","article-title":"Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride","volume":"45","author":"Kim","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/2045125311426896","article-title":"Metabolic:endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study","volume":"1","author":"Kotan","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00439-004-1239-y","article-title":"Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans","volume":"116","author":"Lee","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.psyneuen.2015.12.003_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13049su1c.02","article-title":"Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application","volume":"75","author":"Leucht","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1541-0420.2005.00408.x","article-title":"A mixed-effects regression model for longitudinal multivariate ordinal data","volume":"62","author":"Liu","year":"2006","journal-title":"Biometrics"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial","volume":"31","author":"Malik","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S0033291798006941","article-title":"Co-morbidity and familial aggregation of alcoholism and anxiety disorders","volume":"28","author":"Merikangas","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0145","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.mp.4001860","article-title":"Impact of complex genetic variation in COMT on human brain function","volume":"11","author":"Meyer-Lindenberg","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.tpj.6500441","article-title":"Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment","volume":"7","author":"Molero","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0028-1112132","article-title":"COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia","volume":"42","author":"Neuhaus","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2012.07.048","article-title":"Genetic correlate of cognitive training response in schizophrenia","volume":"64","author":"Panizzutti","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000063574","article-title":"Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels","volume":"46","author":"Schlosser","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/gepi.20028","article-title":"Tag SNP selection for association studies","volume":"27","author":"Stram","year":"2004","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biopsych.2005.10.024","article-title":"Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond","volume":"60","author":"Tunbridge","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopsych.2004.08.012","article-title":"Catechol-O-methyltransferase val108\/158met genotype predicts working memory response to antipsychotic medications","volume":"56","author":"Weickert","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0190","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.pnpbp.2008.05.006","article-title":"Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients","volume":"32","author":"Yasui-Furukori","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0165-1781(02)00022-7","article-title":"Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia","volume":"109","author":"Zhang","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2015.12.003_bib0200","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/YPG.0b013e328358629a","article-title":"Association between a COMT polymorphism and clinical response to risperidone treatment: a pharmacogenetic study","volume":"22","author":"Zhao","year":"2012","journal-title":"Psychiatry Genet."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:51:21Z","timestamp":1759683081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453015300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":40,"alternative-id":["S0306453015300251"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.12.003","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}